Patents by Inventor Per Edvard WALDAY

Per Edvard WALDAY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF CHOLANGIOCARCINOMA WITH TPCS-2A INDUCED PHOTOCHEMICAL INTERNALISATION OF GEMCITABINE
    Publication number: 20200338044
    Abstract: The present invention provides a method of treating a cholangiocarcinoma in a human patient comprising a photochemical internalization method using TPCS2a, and gemcitabine and optionally another cytotoxic agent, preferably cisplatin. Related uses and kit for performing the invention are also provided.
    Type: Application
    Filed: October 13, 2017
    Publication date: October 29, 2020
    Applicant: PCI Biotech AS
    Inventors: Anders HØGSET, Per Edvard WALDAY, Pål Kristian SELBO, Kristin EIVINDVIK, Lena FINNESAND
  • Antigen delivery device and method
    Patent number: 10166401
    Abstract: A device for activating light-induced rupture of endocytic vesicles in target cells of a patient so as to effect delivery of an administered antigen to cytosol in the target cells, is described. The device is adapted to be worn by a patient over a region of skin where an antigen and a photosensitising agent are to be administered. The device comprises a rear surface that is rounded or otherwise configured to be worn against the patient's skin. It has a retaining part for retaining the device in place over the region of the patient's skin during an activation cycle. A light source is arranged to illuminate the patient's skin from the rear of the device. A control system is configured to vary the output of the light source with respect to time in accordance with a pre-configured output sequence.
    Type: Grant
    Filed: August 28, 2014
    Date of Patent: January 1, 2019
    Assignee: PCI BIOTECH AS
    Inventors: Anders Hogset, Per Edvard Walday, Kristin Eivindvik
  • ANTIGEN DELIVERY DEVICE AND METHOD
    Publication number: 20160199664
    Abstract: A device for activating light-induced rupture of endocytic vesicles in target cells of a patient so as to effect delivery of an administered antigen to cytosol in the target cells, is described. The device is adapted to be worn by a patient over a region of skin where an antigen and a photosensitising agent are to be administered. The device comprises a rear surface that is rounded or otherwise configured to be worn against the patient's skin. It has a retaining part for retaining the device in place over the region of the patient's skin during an activation cycle. A light source is arranged to illuminate the patient's skin from the rear of the device. A control system is configured to vary the output of the light source with respect to time in accordance with a pre-configured output sequence.
    Type: Application
    Filed: August 28, 2014
    Publication date: July 14, 2016
    Applicant: PCI Biotech AS
    Inventors: Anders HOGSET, Per Edvard WALDAY, Kristin EIVINDVIK